Skip to main content
SpringerLink
Log in

B-cell Dysfunctions in Autoimmune Diseases

  • Conference paper
National Institute of Allergy and Infectious Diseases, NIH

Part of the book series: Infectious Disease ((ID))

  • 853 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shlomchik MJ, Craft JE, Mamula MJ (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1:147–153.

    Article  PubMed  CAS  Google Scholar 

  2. Reininger L, Radaszkiewicz T, Kosco M, Melchers F, Rolink AG (1992) Development of autoimmune disease in SCID mice populated with long-term “in vitro” proliferating (NZB x NZW)F1 pre-B cells. J Exp Med 176:1343–1353.

    Article  PubMed  CAS  Google Scholar 

  3. Mason LJ, Ravirajan CT, Latchman DS, Isenberg DA (2001) A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of “leaky” SCID mice. Clin Exp Immunol 126:137–142.

    Article  PubMed  CAS  Google Scholar 

  4. Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732–1735.

    Article  PubMed  CAS  Google Scholar 

  5. Radic MZ, Weigert M (1994) Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 12:487–520.

    Article  PubMed  CAS  Google Scholar 

  6. Demaison C, Chastagner P, Theze J, Zouali M (1994) Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephrito-genic anti-DNA idiotype. Proc Natl Acad Sci USA 91:514–518.

    Article  PubMed  CAS  Google Scholar 

  7. Zouali M (1997) The structure of human lupus anti-DNA antibodies. Methods 11:27–35.

    Article  PubMed  CAS  Google Scholar 

  8. Viau M, Zouali M (2005) B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114:17–26.

    Article  PubMed  CAS  Google Scholar 

  9. Weyand CM, Goronzy JJ, Takemura S, Kurtin PJ (2000) Cell-cell interactions in synovitis. Interactions between T cells and B cells in rheumatoid arthritis. Arthritis Res 2:457–463.

    Article  PubMed  CAS  Google Scholar 

  10. Blossom S, Chu EB, Weigle WO, Gilbert KM (1997) CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol 159:4580–4586.

    PubMed  CAS  Google Scholar 

  11. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 1:475–482.

    Article  PubMed  CAS  Google Scholar 

  12. Mauri C, Gray D, Mushtaq N, Londei M (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197:489–501.

    Article  PubMed  CAS  Google Scholar 

  13. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219–230.

    Article  PubMed  CAS  Google Scholar 

  14. Yan J, Harvey BP, Gee RJ, Shlomchik MJ, Mamula MJ (2006) B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol 177:4481–4487.

    PubMed  CAS  Google Scholar 

  15. Liossis SN, Zouali M (2004) B Lymphocyte selection and survival in systemic lupus. Int Arch Allergy Immunol 133:72–83.

    Article  PubMed  Google Scholar 

  16. Zouali M, Sarmay G (2004) B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment. Arthritis Rheum 50:2730–2741.

    Article  PubMed  CAS  Google Scholar 

  17. Zouali M (2005) Molecular Autoimmunity. Springer, New York.

    Book  Google Scholar 

  18. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Boddeker I, Oertel WH, Sommer N, Hemmer B (2001) Patterns of cerebro-spinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124:2169–2176.

    Article  PubMed  CAS  Google Scholar 

  19. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, Mancardi GL, Ferrarini M (2000) Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164:2782–2789.

    PubMed  CAS  Google Scholar 

  20. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, Antel J (1998) Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 102:1045–1050.

    Article  PubMed  CAS  Google Scholar 

  21. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163:5133–5144.

    PubMed  CAS  Google Scholar 

  22. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, Gilden DH (1998) Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43:236–243.

    Article  PubMed  CAS  Google Scholar 

  23. Corcione A, Casazza S, Ferretti E, Giunti D, Zappia E, Pistorio A, Gambini C, Mancardi GL, Uccelli A, Pistoia V (2004) Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA 101:11,064–11,069.

    Article  CAS  Google Scholar 

  24. Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, Sommer N, Hartung HP, Hemmer B (2005) Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128:1667–1676.

    Article  PubMed  Google Scholar 

  25. Ritchie AM, Gilden DH, Williamson RA, Burgoon MP, Yu X, Helm K, Corboy JR, Owens GP (2004) Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cere-brospinal fluid of patients with multiple sclerosis. J Immunol 173:649–656.

    PubMed  CAS  Google Scholar 

  26. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164–174.

    Article  PubMed  Google Scholar 

  27. Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu CM, Kalled SL, Hess DM, Serafini B, Aloisi F, Wekerle H, Hohlfeld R, Meinl E (2005) BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201:195–200.

    Article  PubMed  CAS  Google Scholar 

  28. Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 381:751–758.

    Article  PubMed  CAS  Google Scholar 

  29. Marches R, Vitetta ES, Uhr JW (2001) A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas. Proc Natl Acad Sci USA 98:3434–3439.

    Article  PubMed  CAS  Google Scholar 

  30. Hasler P, Zouali M (2001) B cell receptor signaling and autoim-munity. FASEB J 15:2085–2098.

    Article  PubMed  CAS  Google Scholar 

  31. Nemazee DA, Burki K (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562–566.

    Article  PubMed  CAS  Google Scholar 

  32. Chen C, Nagy Z, Radic MZ, Hardy RR, Huszar D, Camper SA, Weigert M (1995) The site and stage of anti-DNA B-cell deletion. Nature 373:252–255.

    Article  PubMed  CAS  Google Scholar 

  33. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, et al(1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676–682.

    Article  PubMed  CAS  Google Scholar 

  34. Tiegs SL, Russell DM, Nemazee D (1993) Receptor editing in self-reactive bone marrow B cells. J Exp Med 177:1009–1020.

    Article  PubMed  CAS  Google Scholar 

  35. Gay D, Saunders T, Camper S, Weigert M (1993) Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 177:999–1008.

    Article  PubMed  CAS  Google Scholar 

  36. Radic MZ, Zouali M (1996) Receptor editing, immune diversification, and self-tolerance. Immunity 5:505–511.

    Article  PubMed  CAS  Google Scholar 

  37. Lam KP, Kuhn R, Rajewsky K (1997) In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073–1083.

    Article  PubMed  CAS  Google Scholar 

  38. Zouali M (2002) B cell diversity and longevity in systemic auto-immunity. Mol Immunol 38:895–901.

    Article  PubMed  CAS  Google Scholar 

  39. Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2:465–475.

    Article  PubMed  CAS  Google Scholar 

  40. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995–999.

    Article  PubMed  CAS  Google Scholar 

  41. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697–1710.

    Article  PubMed  CAS  Google Scholar 

  42. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, Mackay F (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453– 1466.

    Article  PubMed  CAS  Google Scholar 

  43. Avery DT, Kalled SL, Ellyard JI, Ambrose C, Bixler SA, Thien M, Brink R, Mackay F, Hodgkin PD, Tangye SG (2003) BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112:286–297.

    PubMed  CAS  Google Scholar 

  44. Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S (2000) Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 192:953–964.

    Article  PubMed  CAS  Google Scholar 

  45. Xu LG, Wu M, Hu J, Zhai Z, Shu HB (2002) Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J Leukoc Biol 72:410–416.

    PubMed  CAS  Google Scholar 

  46. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111–2114.

    Article  PubMed  CAS  Google Scholar 

  47. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH (2001) TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15:289–302.

    Article  PubMed  CAS  Google Scholar 

  48. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108–2111.

    Article  PubMed  CAS  Google Scholar 

  49. Bulow GU, von Deursen JM, von Bram RJ (2001) Regulation of the T-independent humoral response by TACI. Immunity 14:573–582.

    Article  Google Scholar 

  50. Laabi Y, Strasser A (2000) Immunology. Lymphocyte survival—ignorance is BLys. Science 289:883–884.

    Article  PubMed  CAS  Google Scholar 

  51. Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP (2002) Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol 168:5993–5996.

    PubMed  CAS  Google Scholar 

  52. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109:59–68.

    PubMed  CAS  Google Scholar 

  53. Zouali M (2005) Taming lupus. Sci Am 292:58–65.

    Article  PubMed  Google Scholar 

  54. Zeng D, Lee MK, Tung J, Brendolan A, Strober S (2000) Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/ NZW mice. J Immunol 164:5000–5004.

    PubMed  CAS  Google Scholar 

  55. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, Bastian H, Kimberly RP, Zhou T (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166:6–10.

    PubMed  CAS  Google Scholar 

  56. Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44:1313–1319.

    Article  PubMed  CAS  Google Scholar 

  57. Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS (2002) BLyS and APRIL form biologically active heterotri-mers that are expressed in patients with systemic immune-based rheumatic diseases. J Immunol 169:4314–4321.

    PubMed  CAS  Google Scholar 

  58. Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 62:168–171.

    Article  PubMed  CAS  Google Scholar 

  59. Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W (2003) Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 48:982–992.

    Article  PubMed  CAS  Google Scholar 

  60. Hermiston ML, Tan AL, Gupta VA, Majeti R, Weiss A (2005) The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity 23:635–647.

    Article  PubMed  CAS  Google Scholar 

  61. Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC (1996) B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal trans-duction events. J Clin Invest 98:2549–2557.

    Article  PubMed  CAS  Google Scholar 

  62. Huck S, Le Corre R, Youinou P, Zouali M (2001) Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity 33:213–224.

    Article  PubMed  CAS  Google Scholar 

  63. Siegel RM, Lenardo MJ (2001) To B or not to B: TNF family signaling in lymphocytes. Nat Immunol 2:577–578.

    Article  PubMed  CAS  Google Scholar 

  64. Wang H, Marsters SA, Baker T, Chan B, Lee WP, Fu L, Tumas D, Y a n M, Dixit VM, Ashkenazi A, Grewal IS (2001) TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol 2:632–637.

    Article  PubMed  CAS  Google Scholar 

  65. Balazs M, Martin F, Zhou T, Kearney J (2002) Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341–352.

    Article  PubMed  CAS  Google Scholar 

  66. Beebe AM, Cua DJ, Waal Malefyt R de(2002) The role of inter-leukin-10 in autoimmune disease: systemic lupus erythemato-sus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13: 403 – 412.

    Article  PubMed  CAS  Google Scholar 

  67. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198–204.

    Article  PubMed  CAS  Google Scholar 

  68. Craxton A, Magaletti D, Ryan EJ, Clark EA (2003) Macro-phage- and dendritic cell—dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101:4464–4471.

    Article  PubMed  CAS  Google Scholar 

  69. Ouarzane M, Zouali M (2006) Novel opportunities for therapeutic targeting in systemic autoimmune diseases. Methods Mol Biol 361:285–298.

    Google Scholar 

  70. Hasler P, Zouali M (2006) B lymphocytes as therapeutic targets in systemic lupus erythematosus. Expert Opin Ther Targets 10:803–815.

    Article  PubMed  CAS  Google Scholar 

  71. Kammer GM, Perl A, Richardson BC, Tsokos GC (2002) Abnormal T cell signal transduction in systemic lupus erythematosus.Arthritis Rheum 46:1139–1154.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by INSERM institutional grants.

Author information

Authors and Affiliations

  1. Inserm, University of Paris, Paris, France

    Moncef Zouali

Authors
  1. Moncef Zouali
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Vassil St. Georgiev PhD Karl A. Western MD John J. McGowan PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this paper

Cite this paper

Zouali, M. (2008). B-cell Dysfunctions in Autoimmune Diseases. In: Georgiev, V.S., Western, K.A., McGowan, J.J. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-569-5_42

Download citation

Publish with us

Policies and ethics

Search

Navigation